Bioanalytical LC–MS/MS validation of therapeutic drug monitoring assays in oncology-Reference-Cited by-同舟云学术

Bioanalytical LC–MS/MS validation of therapeutic drug monitoring assays in oncology

Published:2019-11-27 Issue:1 Volume:34 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Nuland Merel¹²^ORCID,Rosing Hilde¹,Schellens Jan H.M.³,Beijnen Jos H.¹²³

Affiliation:

1. Department of Pharmacy & PharmacologyThe Netherlands Cancer Institute Amsterdam The Netherlands

2. Division of PharmacologyThe Netherlands Cancer Institute Amsterdam The Netherlands

3. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical SciencesUtrecht University Utrecht The Netherlands

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.4623

Reference72 articles.

1. Therapeutic drug monitoring and LC–MS/MS

2. Ion Suppression in Mass Spectrometry

3. Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC–MS/MS assay and ultrafiltration method

4. Importance of matrix effects in LC–MS/MS bioanalysis

5. A New Rapid and Sensitive LC-MS Assay for the Determination of Sorafenib in Plasma: Application to a Patient Undergoing Hemodialysis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Validation of a Volumetric Absorptive Microsampling Method for Therapeutic Drug Monitoring of the Oral Targeted Anticancer Agents, Abiraterone, Alectinib, Cabozantinib, Imatinib, Olaparib, and Sunitinib, and Metabolites;Therapeutic Drug Monitoring;2024-01-30

2. The solvent- and surface-dependent adsorption of the lipopeptide antibiotic daptomycin: The general necessity of adsorption tests;Journal of Pharmaceutical and Biomedical Analysis;2023-10

3. Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab;International Journal of Molecular Sciences;2023-06-20

4. Development and validation of a new bioanalytical method for quantification of CDK4/6 inhibitor in Spiked Human Plasma by HPLC-UV;Current Issues in Pharmacy and Medical Sciences;2023-06-01

5. LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring;Pharmaceutics;2023-05-18